$4.10
-0.39-8.69%
Last update: Nov 10, 7:40 PM
Tonix Pharmaceuticals Holding Corp
TNXPNASDAQ
Tonix Pharmaceuticals fell 74.4% from $17.53 to $4.49, behind the S&P 500's +9.8%. Its worst day was Jul 20 (−11.7%), and its low came Nov 9 at $4.49.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Tonix Pharmaceuticals shares fell 11.3%, while the S&P 500 rose 1.5%.
−11.3% · S&P 500 +1.5%
Story events cover the past 12 months · Times ET
Tonix Pharmaceuticals closed at its highest level of the year, 13.5% above where the year started.
+1.3% · S&P 500 −0.3%
EPS of $-3.98 missed the $-3.03 estimate on $5.4M revenue (est. $2.9M).
−1.3% · S&P 500 −0.6%
Tonix Pharmaceuticals shares rose 14.3%, while the S&P 500 rose 2.9%.
+14.3%, the year's best day · S&P 500 +2.9%
EPS of $-2.93 missed the $-2.51 estimate on $6.9M revenue (est. $7.4M).
−5.9% · S&P 500 −0.2%
Tonix Pharmaceuticals shares fell 11.7%, while the S&P 500 fell 0.2%.
−11.7%, the year's worst day · S&P 500 −0.2%
EPS of $-2.44 beat the $-2.64 estimate on $13.5M revenue (est. $7.8M).
+4.7% · S&P 500 0.0%
EPS of $-2.89 missed the $-2.29 estimate on $17.2M revenue (est. $16.3M).
−5.3% · S&P 500 +2.4%
Where it ended: a close of $4.49 on Nov 9, 2026. Up next: Q4 2026 earnings on Mar 11, 2027 (EPS est. $-2.42, revenue est. $19.8M).
Nothing in the past 12 months.
All TNXP dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TNXP and SPY from Benzinga historical bars. Not investment advice.
